• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS Back to Search Results
Lot Number 0CPEG12
Device Problem Missing Information (4053)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/02/2020
Event Type  malfunction  
Manufacturer Narrative
The patient/family was the initial reporter, so personal information was not entered.No information was captured as the customer's age and weight were not provided.The model # was not provided.This event is related to mdr # 1810909-2021-00007.
 
Event Description
The customer alleged that there was no labeling information on the bottle of the test strips.During the call, the lot # of the test strips was verified from the bottom of the vial.There was no allegation of an adverse event.The customer was advised to return the device for evaluation.A replacement meter kit was sent to the customer.
 
Manufacturer Narrative
The customer did not return the suspected contour next test strips for evaluation.Therefore, the device history record was reviewed for the suspected lot of test strips and no manufacturing anomalies were found.Additionally, the labeling scans were reviewed for the following lot #s 0cpeg12a, 0cpeg12b, 0cpeg12c, and 0cpeg12d based on the raw lot # 0cpeg12, and no labeling issues were identified.During the packaging, a vision inspection test is performed which would remove any vials if there was problem identified with the label.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR NEXT
Type of Device
BLOOD GLUCOSE TEST STRIPS
Manufacturer (Section D)
ASCENSIA DIABETES CARE US INC.
100 summit lake drive
valhalla NY 10595
MDR Report Key11103605
MDR Text Key225155240
Report Number1810909-2021-00010
Device Sequence Number1
Product Code NBW
Combination Product (y/n)N
PMA/PMN Number
P150001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Remedial Action Replace
Type of Report Initial,Followup
Report Date 12/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date03/31/2022
Device Lot Number0CPEG12
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/03/2020
Initial Date FDA Received01/02/2021
Supplement Dates Manufacturer Received01/05/2021
Supplement Dates FDA Received04/15/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-